SGLT-2 inhibitors and GLP-1 receptor agonists could increase the delivery of sodium and water to the cortical collecting duct of the kidney
Phase 3 Development and Current Evidence Level Retatrutide is in phase 3 development for several metabolic indications, including obesity and type 2 diabetes, while published phase 2 trials and 2026 phase 3 reports provide the main current human evidence [2], [7], [8]
Rapid Glutathione Elevation : Unlike standard reduced glutathione that requires weeks of supplementation to show significant increases, S-Acetyl L-Glutathione can rapidly raise intracellular glutathione levels within hours of administration
Drmic et al., Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine, World J
Recent developments in high-throughput NGS have enabled miRNA profiling in biofluids